California Research and Development Credit: The State Credit That Beats Federal §174

The California research and development credit calculation under R&T §23609 starts with the company’s California-source QREs for the current tax year. These are the wages, supplies, contract research payments (at 65 percent), and computer leasing costs tied to qualified research conducted in California. A typical California startup with 25 engineers in San Francisco averaging $200,000 in total compensation generates roughly $5 million in qualified wages. Add $300,000 of supplies and prototype costs and $200,000 of contract research payments (at the 65 percent rate, $130,000 of qualified contract research), and the total California QREs come to roughly $5.43 million for the year.

Under the regular method, the credit is 15 percent of the California QREs above the base amount. The base amount is the larger of 50 percent of current-year QREs ($2.715 million in this example) or the fixed-base percentage times the average gross receipts of the preceding 4 years. For a new startup, the fixed-base percentage starts at 3 percent and may rise over time. A startup with $10 million in average revenue and a 3 percent fixed-base percentage has a fixed-base amount of $300,000, far below the 50 percent floor of $2.715 million. The 50 percent floor controls, and the credit is 15 percent of ($5.43 million minus $2.715 million), or $407,250.

For comparison, the AIRC method would compute the credit on California QREs above 50 percent of the average California QREs for the preceding 3 years. If the startup’s prior 3-year California QRE average was $4 million, the AIRC base is $2 million. The credit is then 1.49 percent on QREs from $2 million to $2.68 million, 1.98 percent on QREs from $2.68 million to $4 million, and 2.48 percent on QREs above $4 million. The total AIRC credit comes to roughly $40,000, dramatically less than the regular method’s $407,250. The regular method wins decisively in this scenario, and almost always wins for high-growth startups whose current QREs significantly exceed the base.

The California research and development credit calculation interacts with federal §41 because the same underlying QRE definitions and four-part test apply. A company that has documented its federal §41 QREs has 90 percent of the work done for the California credit, with only the California-source determination and the apportionment as the additional California-specific steps. The §280C(c) reduction (which reduces the federal QRE deduction by the federal credit amount unless the §280C(c)(3) election is made) does not apply to the California credit because California has no equivalent provision. The California credit is computed on full pre-reduction QREs.

Pass-through entities (S-corps, partnerships, LLCs) compute the California research and development credit at the entity level. The credit appears on Form 3523 and flows to owners on Schedule K-1 (Form 100S, Form 565, or Form 568). For our hypothetical startup organized as a Delaware C-corp doing business in California, the $407,250 California credit is claimed against the corporate franchise tax on Form 100. For a startup organized as a California LLC or S-corp with five owners, the credit flows pro rata to the owners’ Schedule K-1s and is claimed on their personal Form 540 returns.

The non-refundable nature of the California research and development credit limits its immediate utility for pre-profit startups. A startup with no California taxable income generates the credit but cannot use it in the current year. The credit carries forward indefinitely under §23609(g) until the company has California tax liability to offset. For venture-backed startups that lose money for years before becoming profitable, the accumulated credit carryforward can be a significant asset at the time of profitability or acquisition. We have seen startups with $5 million to $20 million in accumulated California R&D credit carryforwards by the time they reach a liquidity event.

Acquisition-related credit utility deserves attention. The California research and development credit carryforwards generally transfer with the underlying corporation in a stock acquisition or merger, subject to the §382 limitations on net operating loss and credit utilization following ownership changes. The §382 limit caps the annual usage of pre-change credits at a formula amount tied to the long-term tax-exempt rate times the acquired company’s value. For startups acquired at high valuations, the §382 limit is often high enough to permit full credit utilization. For startups acquired in distress, the limit can be very low and effectively forfeits much of the credit value.

The California research and development credit can be transferred or sold under R&T §23663 in limited circumstances. Most companies cannot sell or transfer the credit. It must be used by the original taxpayer or by the same taxpayer in a combined report. The combined report mechanics for California-affiliated groups (under the water’s-edge or worldwide combined election) can allow the credit to be used by other entities in the same combined group, which is useful for corporate structures with multiple California subsidiaries. Most startups do not have this complexity.

The Reed Corporation works with California R&D-active clients to compute the California research and development credit annually using the more favorable of the regular or AIRC methods, document the QREs at the project level, and maintain the four-part test analysis contemporaneously. For new clients, we audit the prior three years of credit claims to identify under-claimed credits and amend Form 3523 returns where the credit was missed or undercounted. For acquisition-stage clients, we coordinate with the acquirer’s tax team to preserve the credit carryforward through the transaction structure where possible. The credit value over a multi-year period for a serious R&D-active California company can easily exceed $1 million and is worth the investment in clean documentation and proper computation.

One frequently missed aspect of the California research and development credit calculation is the gross receipts denominator in the fixed-base percentage. For the regular method, the base amount uses the average gross receipts of the preceding 4 years, which means companies with rapid revenue growth see their base amount expand as gross receipts climb. This is intentional in the statute and is designed to prevent the credit from rewarding pure revenue growth (which dilutes the QRE-to-receipts ratio). For a startup whose revenue grows from $5 million in 2023 to $50 million in 2026, the 4-year average gross receipts is roughly $20 million, and the base amount climbs so. The credit still applies if QREs grow faster than gross receipts, but it shrinks if QRE growth lags revenue growth. We model this trajectory for clients projecting major revenue growth so the credit value is captured before the base expansion neutralizes the QRE growth. Year-over-year credit modeling is an annual exercise that catches base-amount creep before it eliminates the credit benefit entirely.

The California research and development credit and the federal §41 credit share the same underlying definitions of qualified research, the four-part test, and the QRE categories, but they differ in important ways. The federal §41 credit is 20 percent of QREs above the base under the regular method, or 14 percent of QREs above 50 percent of the average of the preceding 3 years under the alternative simplified credit (ASC). The California credit is 15 percent under the regular method or the AIRC rates of 1.49 to 2.48 percent. The federal rates are higher, but the California credit applies on top of the federal credit, generating combined value above either credit alone.

The geographic scope differs. The federal §41 credit applies to qualified research conducted within the United States (with limited exceptions for research in U.S. territories). The California research and development credit applies only to research conducted in California. A company with research in California and Texas claims the federal credit on all of it but the California credit only on the California portion. The geographic split is the first major California-specific adjustment in the credit computation.

The §280C(c) reduction at the federal level reduces the federal §174 deduction by the federal §41 credit amount unless the company makes the §280C(c)(3) election to take a reduced credit (effectively at 79 percent of the regular credit rate). The election trade-off depends on the company’s marginal tax rate. California has no equivalent §280C provision, so the California credit does not reduce the California deduction. The full California deduction stays in place even when the California research and development credit is claimed.

The §174 capitalization regime applies federally but not in California. Federal research expenses must be amortized over 5 years (15 years foreign) starting in 2022, while California still allows immediate deduction. This creates a substantial book-tax difference at the federal level. The California return reports the full deduction in the year incurred, generating much lower California taxable income than federal taxable income for R&D-heavy companies. The combination of immediate California deduction plus the California research and development credit makes California one of the most favorable states for R&D-active companies despite the high tax rates.

The carryforward periods differ. The federal §41 credit carries back 1 year and forward 20 years. The California research and development credit has no carryback but unlimited carryforward under §23609(g). For pre-profit startups, the indefinite California carryforward is more valuable than the 20-year federal carryforward because it preserves the credit through long pre-profit periods. For mature companies with consistent profits, the difference is less material because both credits get used within the carryforward window.

The basic research component differs in rate. The federal §41 basic research credit (for payments to universities and qualified scientific organizations) is 20 percent, the same as the federal regular research credit. The California research and development credit basic research component is 24 percent, higher than the California regular credit’s 15 percent. For companies with significant university research collaborations, the California credit is materially more favorable on the basic research dollar than the federal credit. We have seen biotech clients with multi-million-dollar university research arrangements where the California 24 percent rate produced a meaningfully larger credit than the federal 20 percent rate on the same payments.

Refundability and payroll tax offset differ. The federal §41 credit can offset payroll taxes for qualified small businesses (under §41(h), the payroll tax election) up to $500,000 per year. The California research and development credit has no equivalent payroll tax offset. For pre-revenue startups with no income tax liability but significant payroll, the federal payroll tax offset is uniquely valuable and has no California counterpart. The California credit accumulates in the carryforward until the company has California tax to offset it.

Documentation standards are similar but not identical. Both the IRS and the FTB require contemporaneous documentation of the four-part test, wage qualification, supplies, and contract research. The IRS Audit Technique Guide and the FTB Audit Manual contain substantially similar guidance. The FTB tends to be slightly more aggressive in challenging contract research arrangements and wage allocations for employees with mixed roles. Best practice is to maintain documentation that satisfies both standards, which means documentation that satisfies the more demanding of the two on each specific point.

The combined federal-plus-California benefit on a $5 million California R&D expenditure can be significant. The federal credit at 14 to 20 percent on the incremental amount produces $400,000 to $1 million in federal tax reduction. The California research and development credit at 15 percent on the incremental amount produces $300,000 to $750,000 in California tax reduction. The California §174 conformity miss saves the company from the federal phantom income issue at the California level entirely. The total tax benefit on R&D spending in California, properly captured, can run 25 to 35 percent of the qualified expenditure when both federal and California are layered together. This is one of the most favorable tax positions available to any U.S. business, and we routinely see California-based R&D-active companies under-claiming both credits because their prior tax preparers were not specialized in the area. The cost of fixing under-claimed credits through amended returns is small compared to the cash recovery on three to six years of prior filings.

California research and development credit cash value also interacts with state tax planning around §174 conformity. Since California does not conform to the federal §174 capitalization regime, California taxable income for R&D-heavy companies is significantly lower than federal taxable income. The pass-through entity tax (PTE) election under AB 150 can generate a federal SALT deduction for California-resident owners on the entity-level California tax payment. The PTE payment is computed on California taxable income (after the immediate §174 deduction), not federal taxable income (after the 5-year §174 amortization). This produces a smaller PTE tax than would otherwise apply if California conformed to §174, which means less federal SALT deduction. The interaction is favorable for cash flow (less current tax) but less favorable for federal SALT capture (smaller deduction). The net effect depends on the owner’s federal tax rate and the multi-year trajectory of the company. For most R&D-active California companies, the cash flow benefit of immediate §174 deduction outweighs the smaller PTE deduction, but the analysis should be run explicitly rather than assumed.

The California research and development credit requires contemporaneous documentation of qualified research activities, qualified wages, qualified supplies, and qualified contract research. The FTB applies essentially the same documentation standards as the IRS under §6001 and the §41 regulations. The documentation must establish that each business component (the product, process, software, or formula being developed) meets the four-part test, and that the specific expenses claimed are tied to qualified research activities.

The four-part test documentation is the heart of the analysis. Under §41(d)(1), qualified research must be (1) technological in nature, relying on principles of physical, biological, computer science, or engineering disciplines, (2) intended to discover information that eliminates uncertainty about the development or improvement of a business component, (3) involve a process of experimentation, including evaluation of alternatives, testing of hypotheses, and refinement based on results, and (4) be undertaken for a qualified purpose (new or improved function, performance, reliability, or quality). Each business component needs documentation addressing each of the four elements.

Documentation of the technological uncertainty (the second part of the test) is often the weakest area in audit defenses. The FTB looks for evidence that the company genuinely did not know how to achieve the desired result at the start of the project. Routine engineering work, application of known principles, and standard implementations do not meet the uncertainty requirement. The documentation should specifically articulate what was unknown at the project’s inception and what the alternative approaches were that the company evaluated. Project planning documents, design specifications, and engineering review notes often contain this evidence if they are prepared as part of the normal workflow.

The California research and development credit wage documentation requires tracking each researcher’s qualified research time. For employees whose entire role is qualified research, 100 percent of W-2 box 1 wages qualify. For employees with mixed roles, only the qualified research portion qualifies. Time-tracking systems (timesheets, project tracking tools, calendar reviews) provide the contemporaneous evidence. The FTB will accept reasonable estimates under the Cohan principle where time tracking is incomplete, but the estimates must be supported by some contemporaneous evidence (project plans, role descriptions, interviews with the researchers).

Supply documentation requires invoices, purchase orders, and consumption records showing that supplies were used in qualified research. The Treasury Regulations under §41 require that supplies be either used or consumed in the research, not retained as capital assets. Lab consumables, prototype materials, and testing supplies generally qualify. Tools, equipment, and computers do not qualify (they fall under depreciable property excluded by §41(b)(2)(C)). The classification can be ambiguous for items like custom hardware built for research that may later have commercial use. Best practice is to document the research consumption explicitly and segregate research supplies from production supplies.

Contract research documentation requires the contractor agreement, the scope of work, and evidence that the research was performed in California (for the California-specific geographic requirement). The agreement should establish that the company bears the risk of the research (a key requirement under Reg. §1.41-2(e)) and that the company retains substantial rights in the research results. Cost-plus and fixed-price arrangements where the contractor bears no economic risk often do not qualify because the contracting company is buying a finished product rather than funding research. The economic risk allocation is one of the most contested points in contract research audits.

The California research and development credit project documentation should be maintained at the business component level, not at the company level. A company with five product lines that each involve qualified research should maintain separate four-part test documentation for each product line. Aggregated documentation that lumps all R&D into one analysis is heavily discounted by FTB auditors because it does not allow them to verify the qualified research nature of specific activities. The project-level documentation also helps in audits where some projects are challenged and others are not, allowing the company to defend the unchallenged credit portion without compromising the entire claim.

Software development presents specific documentation challenges. Under §41(d)(4)(E), internal use software has more restrictive qualification requirements than software developed for external sale. The three-part test for internal use software (new, significant economic risk, not commercially available) limits the credit for back-office software, custom internal tools, and similar systems. External use software (sold to customers or used by customers via SaaS) has the standard four-part test and is more accessible. The documentation should specifically address the internal versus external use classification with reference to the regulatory definitions.

The Reed Corporation builds California research and development credit documentation systems for clients in real time. Our standard approach is to identify the qualified business components at the start of each tax year, set up project tracking with explicit four-part test fields, run quarterly documentation reviews with the engineering team, and produce a year-end credit memo that captures the project-by-project analysis. The cost of building the documentation contemporaneously is far less than the cost of reconstructing it from incomplete records during an FTB audit. For clients with existing under-documented credit claims, we run reconstruction projects that piece together the available evidence and produce defensible documentation memos, typically saving 60 to 80 percent of credit value compared to losing the credit entirely on audit.

Documentation quality also drives the audit outcome for California research and development credit claims involving acquired entities, spin-offs, and corporate restructurings. The pre-transaction QRE history transfers with the acquired entity, but the documentation files often do not transfer cleanly because the acquired company’s records may be incomplete or unavailable post-acquisition. We have run reconstruction projects on acquired R&D credits worth $500,000 to $2 million where the original documentation was in former employees’ personal files, in archive systems that the buyer never accessed, or in shared drives that were not part of the deal documents. The reconstruction can succeed if enough evidence exists (project lists, engineering documents from public filings, customer case studies), but the cost is significant (often $100,000 to $250,000 in specialty firm fees) and the credit recovery rate is typically 60 to 80 percent rather than 100 percent. Buyer-side acquisition due diligence should specifically require complete R&D credit documentation files as part of the deal data room, not as an afterthought. We help clients build this requirement into purchase agreements to avoid the post-closing scramble.

The California research and development credit for pass-through entities is computed at the entity level on Form 3523 and passed to owners on Schedule K-1. The mechanics differ from the federal §41 credit, which is also pass-through but uses different K-1 attachment formats. For California, the credit appears on the appropriate Schedule K-1 line item (varies by entity type and form year), and the owner claims the credit on their personal Form 540 or Form 540NR. The credit is non-refundable but carries forward indefinitely at the owner level.

S-corp owners receive their share of the California research and development credit based on their pro rata stock ownership under §1366. There are no special allocations for S-corps because they have a single class of stock and pro rata sharing is mandatory. An owner with 25 percent of the S-corp stock receives 25 percent of the credit. The credit appears on Schedule K-1 (Form 100S) and flows to Form 540, where it offsets the owner’s California personal income tax liability for the year.

Partnership and LLC (taxed as partnership) credit allocations follow §704(b) and §704(c) principles. The default is allocation according to the partners’ interests in the partnership, which usually tracks the profit-sharing ratios. Special allocations of credits are permitted under §704(a) if they have substantial economic effect under Treas. Reg. §1.704-1(b)(2). Special allocations of credits are rare in practice because the credit value is small relative to operating income, but they can be used in venture-backed structures where preferred holders want to allocate credits to themselves disproportionately. The structuring requires careful drafting.

The California research and development credit for nonresident owners requires the owner to file a California nonresident return (Form 540NR) to claim the credit. A New York resident owner of a California LLC that generates a $50,000 credit on Schedule K-1 must file Form 540NR to claim the credit against any California tax liability the owner has from California-source income. If the owner has no California tax liability for the year, the credit carries forward indefinitely on the owner’s California carryforward records. The owner must file Form 540NR each year to maintain the carryforward, even if no California tax is due in subsequent years.

Single-member LLC owners claim the California research and development credit directly on their personal return because the LLC is disregarded for income tax purposes. The credit appears on the owner’s Form 3523 attached to Form 540 or Form 540NR. The entity-level Form 568 still files in California for the $800 tax and §17942 fee, but the credit flows directly to the owner’s individual return without going through a K-1.

Multi-state pass-through entities (LLCs or partnerships doing business in California and other states) apportion their total QREs using the California apportionment percentage. Only California-source QREs generate California research and development credit. The apportionment runs at the entity level on Form 3523, and the resulting California credit allocates to owners on Schedule K-1. Owners then claim the credit on their California returns based on their share of the entity’s credit, not based on their share of the entity’s apportioned California income.

The non-refundable nature of the California research and development credit means the credit can only reduce the owner’s California tax liability to zero in any year, with the excess carried forward. For owners with no California income (and so no California tax) in the year the credit is generated, the entire credit carries forward to future years. This is common for venture-backed LLC structures where most owners are out-of-state institutional investors with no California tax exposure. The credit accumulates in the carryforward until the owner has California tax to offset, which may not happen for years.

California pass-through entity tax (PTE) election under AB 150 interacts with the California research and development credit. A pass-through entity that elects PTE tax pays California income tax at the entity level (currently 9.3 percent on California-source income). The entity-level California tax is then offset by the California research and development credit at the entity level on Form 3523 before the remaining tax is paid. The federal SALT deduction for the PTE payment is generated on the entity’s federal return. This can produce significant federal tax savings for owners while still capturing the California credit, but the mechanics require careful coordination between the PTE election and the credit utilization.

The Reed Corporation handles California research and development credit allocations for pass-through entity clients with detailed K-1 mechanics, owner-level tracking of carryforwards across years, and coordination with the PTE election where applicable. For clients with multiple pass-through entities and multiple owners, the credit tracking can become complex, particularly when ownership changes year over year. We maintain owner-level credit carryforward schedules that track the credit generation year, the carryforward balance, and the projected utilization. The cost of clean credit tracking is small compared to the cost of losing carryforward credits due to incomplete records, which we see frequently with new clients whose prior tax preparers did not maintain proper credit history.

The California research and development credit for partnership owners with §704(c) tax considerations adds complexity that few practitioners flag. When a partnership has assets contributed at a book value different from tax basis (the §704(c) gain or loss layer), the resulting allocations to partners can produce credit allocation inconsistencies if not coordinated carefully. The credit follows the partners’ interests in the partnership under §704(a), which generally tracks profit-sharing ratios. But if §704(c) requires allocating specific tax items disproportionately, the credit allocation can drift away from the economic profit-sharing ratio. We have seen partnership agreements with poorly drafted §704(c) provisions produce credit allocations that contradict the economic deal. The fix is amending the partnership agreement to explicitly address credit allocation alongside the §704(c) tax allocations. For startups raising venture capital with §704(c) layers from earlier funding rounds, this drafting issue is common and easily overlooked until a credit allocation dispute surfaces among partners. We review the credit allocation provisions of every partnership agreement we encounter during a new client engagement, and we have proposed redline amendments to allocation provisions in roughly a third of those agreements where the drafting did not address the California research and development credit specifically. The cost of the amendment is small and the clarity is worth it to all partners.

The FTB audits California research and development credit claims more aggressively than most other credits because the dollar amounts are often material and the qualification standards involve judgment-based determinations. Common audit issues include insufficient four-part test documentation, overclaimed employee wages, misclassified contract research, supply costs that should have been capitalized, and projects that fail one or more elements of the qualified research definition.

Insufficient four-part test documentation is the single most common audit issue. The FTB requests project-by-project documentation showing that each business component meets all four elements of the test. Companies that maintain only aggregated R&D records or that prepared four-part test analyses only after the audit notice are heavily disadvantaged. The audit typically requests contemporaneous engineering documents (design specs, project plans, technical review notes) and interviews with key researchers about the technological uncertainty being addressed. Without contemporaneous documents, the credit reduction can be 50 percent or more.

Overclaimed wages are the second most common audit issue. Companies often claim 100 percent of an engineer’s salary as qualified wages without supporting time-tracking evidence. Auditors review actual work performed, including time spent on production support, customer-facing engineering, sales engineering, management activities, and other non-qualified work. The reduction can be substantial for senior engineers and engineering managers whose time is split between research and operations. Best practice is to maintain time-tracking records during the year, even rough ones, to support whatever percentage is claimed.

Misclassified contract research catches many companies that pay outside developers, contract research organizations, or consultants for engineering work. The qualifying conditions for contract research are demanding: the company must bear the economic risk of the research, the company must retain substantial rights in the research results, and the research must be performed in California for the California credit. Cost-plus contracts where the contractor is essentially being paid for time without research risk often fail the economic risk test. Fixed-price contracts where the company is buying a finished deliverable often fail the substantial rights test. The 65 percent qualified rate applies only to true qualified contract research, and overclaims are common.

Supply costs that should have been capitalized as depreciable property are another frequent audit issue. The exclusion under §41(b)(2)(C) for property of a character subject to depreciation eliminates many items that taxpayers include as supplies. Specialized equipment built or purchased for research, including custom hardware, fabrication tools, and testing instruments, generally must be capitalized and depreciated rather than treated as consumed supplies. The audit looks at the useful life of the item, whether it remained available after the research was complete, and whether the company depreciated it on the federal return.

Projects that fail one or more elements of the qualified research definition are sometimes wholesale challenged by the FTB. Software development projects often face issues with the internal use software restrictions under §41(d)(4)(E). Routine engineering and product improvement projects sometimes lack the requisite technological uncertainty. Customer-specific custom development that does not advance the company’s product or process can fail the qualified purpose test. The audit typically focuses on the largest projects and works down, so concentrating the credit on a few clearly qualifying projects is often a better defensive position than spreading it across many marginal projects.

The California-source geographic requirement is sometimes overlooked. The California research and development credit applies only to research conducted in California. For multi-state companies, the California-source QREs are a subset of the total QREs claimed on the federal §41 credit. Companies that simply use the federal QRE total for the California credit without separating the California-conducted portion overclaim the California credit substantially. Auditors check this carefully, especially for companies with research operations in lower-cost states like Texas, Florida, or Washington alongside California operations.

Apportionment errors compound the geographic issues for multi-state companies. The California QREs must reflect actual California-conducted research, not just the California apportionment percentage applied to total QREs. A company with 30 percent of its apportionment factors in California but 60 percent of its researchers in California has 60 percent California QREs, not 30 percent. Conversely, a company with 50 percent California apportionment but only 20 percent of researchers in California has 20 percent California QREs. The auditors compare headcount, payroll, and project documentation to confirm the California-source share is properly computed.

The Reed Corporation defends California research and development credit audits regularly. The typical defense pattern is to start with the strongest projects (clearest four-part test compliance, highest documentation quality), work through to the marginal projects, and identify any items that should be conceded to focus the defense on the defensible portion of the claim. We coordinate with R&D credit specialty firms for the engineering and documentation reconstruction work where needed. The cost of audit defense is typically 5 to 15 percent of the credit value being defended. For credits above $200,000, the defense investment is almost always justified by the credit value at stake. For credits below $50,000, the audit defense cost can sometimes approach the credit value, and a partial concession may be the practical resolution. Each case depends on the specific facts and the FTB auditor’s focus areas, which vary by region and audit team.

Strategic audit defense for the California research and development credit also requires understanding the FTB’s appeal process when initial determinations are unfavorable. The FTB’s protest process under R&T §19044 allows the taxpayer to challenge the audit determination within 60 days of the Notice of Proposed Assessment. The protest is reviewed by an FTB Hearing Officer separate from the original auditor, which often produces a more reasonable outcome than the audit determination. Further appeal to the Office of Tax Appeals (OTA) under R&T §19045 is available within 30 days of the protest decision. The OTA is an independent body that has produced several taxpayer-favorable decisions on R&D credit issues in recent years. Pursuing the protest and OTA appeal can be costly (typically $25,000 to $100,000 in professional fees) but is often justified for credit amounts above $250,000 where the FTB has taken an aggressive position. We coordinate with R&D credit specialty firms and tax controversy attorneys for the OTA work where the credit value warrants the investment. For clients with credits below the OTA threshold, the cheaper resolution is usually a negotiated settlement at the protest stage that captures 50 to 70 percent of the disputed amount without the cost of further appeal.